Kintegral Advisory’s Celgene CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-17,299
Closed -$1.72M – 269
2019
Q3
$1.72M Hold
17,299
– – 0.34% 84
2019
Q2
$1.6M Hold
17,299
– – 0.32% 90
2019
Q1
$1.63M Buy
17,299
+8,087
+88% +$707K 0.34% 87
2018
Q4
$590K Hold
9,212
– – 0.17% 117

Other funds holding CELG

Kintegral Advisory's CELG Position: Q4 2019 in Review

Kintegral Advisory sold out of Celgene (CELG) in Q4 2019, closing a stake of 17,299 shares — an estimated $1.72M sold.

Kintegral Advisory first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $1.72M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Kintegral Advisory reported no remaining Celgene position as of Q4 2019 after selling out during the quarter.
  • Kintegral Advisory sold 17,299 Celgene shares in Q4 2019, an estimated $1.72M.
  • Kintegral Advisory first reported a position in Celgene in Q4 2018 and held it in 4 quarters.
  • Kintegral Advisory's Celgene position peaked at $1.72M in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Celgene as of Q4 2019.

Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.